APA (7th ed.) Citation

Mossop, H., Grayling, M. J., Gallagher, F. A., Welsh, S. J., Stewart, G. D., & Wason, J. M. S. (2022). Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. British journal of cancer, 126(2), 204-210. https://doi.org/10.1038/s41416-021-01613-5

Chicago Style (17th ed.) Citation

Mossop, Helen, Michael J. Grayling, Ferdia A. Gallagher, Sarah J. Welsh, Grant D. Stewart, and James M S. Wason. "Advantages of Multi-arm Non-randomised Sequentially Allocated Cohort Designs for Phase II Oncology Trials." British Journal of Cancer 126, no. 2 (2022): 204-210. https://doi.org/10.1038/s41416-021-01613-5.

MLA (9th ed.) Citation

Mossop, Helen, et al. "Advantages of Multi-arm Non-randomised Sequentially Allocated Cohort Designs for Phase II Oncology Trials." British Journal of Cancer, vol. 126, no. 2, 2022, pp. 204-210, https://doi.org/10.1038/s41416-021-01613-5.